Table 4.
Item | Parameter | Co-efficient | Standard error | 95% Confidence interval (CI) | Z-value | Pr>|Z| | |
---|---|---|---|---|---|---|---|
Intercept | 6.4430 | 0.0640 | 6.3176 | 6.5683 | 100.74 | <0.0001 | |
Treatment modality | Nasal clip | −0.2748 | 0.0650 | −0.4023 | −0.1474 | −4.23 | <0.0001 |
No treatment | −0.9752 | 0.1351 | −1.2401 | −0.7104 | −7.22 | <0.0001 | |
Other treatment | −0.7523 | 0.0907 | −0.9301 | −0.5745 | −8.29 | <0.0001 | |
Silver nitrate | −0.2391 | 0.0373 | −0.3123 | −0.1659 | −6.40 | <0.0001 | |
Vaseline | 0.0062 | 0.0505 | −0.0929 | 0.1053 | 0.12 | 0.9024 | |
Merocel® | Reference | ||||||
Gender | Male | 0.0564 | 0.0309 | −0.0041 | 0.1169 | 1.83 | 0.0675 |
Female | Reference | ||||||
Co-morbid condition | At least 1 condition | 0.0527 | 0.0410 | −0.0276 | 0.1331 | 1.29 | 0.1981 |
No condition | Reference | ||||||
Age | 0.0010 | 0.0010 | −0.0009 | 0.0029 | 1.06 | 0.2907 | |
Concomitant medication | At least 1 medication | 0.0272 | 0.0444 | −0.0599 | 0.1143 | 0.61 | 0.5405 |
No medication | Reference | ||||||
Type of epistaxis | Recurrent | −0.0694 | 0.0486 | −0.1647 | 0.0259 | −1.43 | 0.1533 |
Initial | Reference | ||||||
Quasi-Akaike information criterion | 268.61 |